Resveratrol protects the ovary against chromium-toxicity by enhancing endogenous antioxidant enzymes and inhibiting metabolic clearance of estradiol

Toxicology and Applied Pharmacology

Volumn 303, Issue , 2016, Pages 65-78

  Banu, Sakhila K ^a   Stanley, Jone A ^a   Sivakumar, Kirthiram K ^a   Arosh, Joe A ^a   Burghardt, Robert C ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Antioxidants; Chromium; Ovary; Oxidative Stress; Resveratrol; Steroidogenesis

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANTIOXIDANT; AROMATASE; ATAXIN 2; CASPASE 3; CATALASE; CHROMIUM; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C; ESTRADIOL; GLUTATHIONE PEROXIDASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPID PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; PEROXIREDOXIN 3; PROTEIN BCL 2; PROTEIN BCL XL; RESVERATROL; STEROIDOGENIC ACUTE REGULATORY PROTEIN; CARCINOGEN; CHROMIUM HEXAVALENT ION; GLUTATHIONE PEROXIDASE; POLLUTANT; PROGESTERONE; PROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; STILBENE DERIVATIVE; SUPEROXIDE DISMUTASE; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST MILK; CELL DEATH; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; ESTROGEN METABOLISM; FEMALE; GLUCURONIDATION; HEAVY METAL POISONING; HYDROXYLATION; LACTATION; LIPID PEROXIDATION; METABOLIC CLEARANCE; NONHUMAN; OVARY; OVARY FOLLICLE ATRESIA; OXIDATIVE STRESS; PUERPERIUM; RAT; SULPHATION; UPREGULATION; ANIMAL; APOPTOSIS; BLOOD; DRUG EFFECTS; KIDNEY; LIVER; METABOLISM; NEWBORN; OOCYTE; PATHOLOGY; POLLUTANT; PREGNANCY; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CARCINOGENS; CATALASE; CHROMIUM; ENVIRONMENTAL POLLUTANTS; ESTRADIOL; FEMALE; FOLLICULAR ATRESIA; GLUTATHIONE PEROXIDASE; KIDNEY; LIVER; OOCYTES; OVARY; PREGNANCY; PROGESTERONE; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; STILBENES; SUPEROXIDE DISMUTASE; TESTOSTERONE;

EID: 84968725141     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2016.04.016     Document Type: Article

References (90)

1. Agarwal B., Baur J.A. Resveratrol and life extension. Ann. N. Y. Acad. Sci. 2011, 1215:138-143.
2. Ahmed K.A., Clement M.-V., Pervaiz S. Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxide-induced apoptosis. Ann. N. Y. Acad. Sci. 2003, 1010:365-373.
3. Armienta-Hernández M.A., Rodríguez-Castillo R. Environmental exposure to chromium compounds in the valley of León, México. Environ. Health Perspect. 1995, 103:47-51.
4. Asadi S., Goodarzi M.T., Saidijam M., Karimi J., Azari R.Y., Farimani A.R., Salehi I. Resveratrol attenuates visfatin and vaspin genes expression in adipose tissue of rats with type 2 diabetes. Iran. Bosn. J. Basic Med. Sci. 2015, 18:537.
5. Banu S.K. Heavy metals and the ovary. Ovarian Toxicology 2013, 191-228. CRC Press, Second Edition. P.B. Hoyer (Ed.).
6. Banu S.K., Samuel J.B., Arosh J.A., Burghardt R.C., Aruldhas M.M. Lactational exposure to hexavalent chromium delays puberty by impairing ovarian development, steroidogenesis and pituitary hormone synthesis in developing Wistar rats. Toxicol. Appl. Pharmacol. 2008, 232:180-189.
7. Banu S.K., Stanley J.A., Lee J., Stephen S.D., Arosh J.A., Hoyer P.B., Burghardt R.C. Hexavalent chromium-induced apoptosis of granulosa cells involves selective sub-cellular translocation of Bcl-2 members, ERK1/2 and p53. Toxicol. Appl. Pharmacol. 2011, 251:253-266.
8. Banu S.K., Stanley J.A., Sivakumar K.K., Arosh J.A., Barhoumi R., Burghardt R.C. Identifying a novel role for X-prolyl aminopeptidase (Xpnpep) 2 in CrVI-induced adverse effects on germ cell nest breakdown and follicle development in rats. Biol. Reprod. 2015, 92:67.
9. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
10. Beaudeux J.-L., Nivet-antoine V., Giral P. Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:729-736.
11. Blacksmith-Institute World Worst Pollution Problems 2015, 1-36. Pure Earth and Green Cross Switzerland - The Blacksmith Institute, New York City, USA.
12. Borgeest C., Symonds D., Mayer L.P., Hoyer P.B., Flaws J.A. Methoxychlor may cause ovarian follicular atresia and proliferation of the ovarian epithelium in the mouse. Toxicol. Sci. 2002, 68:473-478.
13. Burkhardt S., Reiter R.J., Tan D.X., Hardeland R., Cabrera J., Karbownik M. DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid. Int. J. Biochem. Cell Biol. 2001, 33:775-783.
14. Chen Z.H., Hurh Y.J., Na H.K., Kim J.H., Chun Y.J., Kim D.H., Kang K.S., Cho M.H., Surh Y.J. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 2004, 25:2005-2013.
15. Chen Z.G., Luo L.L., Xu J.J., Zhuang X.L., Kong X.X., Fu Y.C. Effects of plant polyphenols on ovarian follicular reserve in aging rats. This paper is one of a selection of papers published in this special issue entitled "Second International Symposium on Recent Advances in Basic, Clinical, and Social Medicine" and has undergone the Journal's usual peer review process. Biochem. Cell Biol. 2010, 88:737-745.
16. Clement M.V., Hirpara J.L., Chawdhury S.H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998, 92:996-1002.
17. ContaminatedRealty victims town of hinkley (Hinkley, CA, pp). http://www.victimstownofhinkley.org/.
18. Das D.K., Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol. Interv. 2006, 6:36-47.
19. Dawson A.P. The biological roles of steroid sulfonation. Steroids - From Physiology to Clinical Medicine 2012, 45-64. M.O. Sergej (Ed.).
20. Devine P.J., Sipes I.G., Skinner M.K., Hoyer P.B. Characterization of a rat in vitro ovarian culture system to study the ovarian toxicant 4-vinylcyclohexene diepoxide. Toxicol. Appl. Pharmacol. 2002, 184:107-115.
21. Dominik J., Vignati D.A.L., Koukal B., Pereira de Abreu M.H., Kottelat R., Szalinska E., Baś B., Bobrowski A. Speciation and environmental fate of chromium in rivers contaminated with tannery effluents. Eng. Life Sci. 2007, 7:155-169.
22. Dubey C., Sahoo B., Nayak N. Chromium (VI) in waters in parts of Sukinda chromite valley and health hazards, Orissa, India. Bull. Environ. Contam. Toxicol. 2001, 67:541-548.
23. Fang Z., Zhao M., Zhen H., Chen L., Shi P., Huang Z. Genotoxicity of tri- and hexavalent chromium compounds in vivo and their modes of action on DNA damage in vitro. PLoS One 2014, 9.
24. Gaikwad N.W., Rogan E.G., Cavalieri E.L. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic. Biol. Med. 2007, 43:1289-1298.
25. Garvin S., Öllinger K., Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett. 2006, 231:113-122.
26. Gibellini L., Bianchini E., De Biasi S., Nasi M., Cossarizza A., Pinti M. Natural compounds modulating mitochondrial functions. Evid. Based Complement. Alternat. Med. 2015, 2015:1-13.
27. Gordon T.R. Documentation of environmental indicator determination - Interim Final 2/5/99. U. S. Environmental Protection Agency - Region 2, New York, NY 2003, 1-19.
28. Hakkola J., Pasanen M., Pelkonen O., Hukkanen J., Evisalmi S., Anttila S., Rane A., Mantyla M., Purkunen R., Saarikoski S., Tooming M., Raunio H. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 1997, 18:391-397.
29. Hall D. Nutritional influences on estrogen metabolism. Appl. Nutr. Sci. Rep. 2001, 1:1-8.
30. Hanet N., Lancon A., Delmas D., Jannin B., Chagnon M.C., Cherkaoui-Malki M., Latruffe N., Artur Y., Heydel J.M. Effects of endocrine disruptors on genes associated with 17beta-estradiol metabolism and excretion. Steroids 2008, 73:1242-1251.
31. Hemminki K., Niemi M.L., Koskinen K., Vainio H. Spontaneous abortions among women employed in the metal industry in Finland. Int. Arch. Occup. Environ. Health 1980, 47:53-60.
32. Hemminki K., Kyyronen P., Niemi M.L., Koskinen K., Sallmen M., Vainio H. Spontaneous abortions in an industrialized community in Finland. Am. J. Public Health 1983, 73:32-37.
33. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.-L. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
34. Huber J., Tempfer-Bentz E.-K., Ott J., Tempfer C. Estrogen-metabolizing gene polymorphisms, genetic susceptibility, and pharmacogenomics. The Role of Genetics in Breast and Reproductive Cancers 2010, 285-314. Springer, New York. P. Welcsh (Ed.).
35. Imamura G., Bertelli A.A., Bertelli A., Otani H., Maulik N., Das D.K. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:1996-2003.
36. Johnson W., Morrissey R., Usborne A., Kapetanovic I., Crowell J., Muzzio M., McCormick D. Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem. Toxicol. 2011, 49:3319-3327.
37. Juan M.E., Gonzalez-Pons E., Munuera T., Ballester J., Rodríguez-Gil J.E., Planas J.M. trans-Resveratrol, a natural antioxidant from grapes, increases sperm output in healthy rats. J. Nutr. 2005, 135:757-760.
38. Kode A., Rajendrasozhan S., Caito S., Yang S.R., Megson I.L., Rahman I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L478-L488.
39. Kratzer D.D., Littell R.C. Appropriate statistical methods to compare dose responses of methionine sources. Poult. Sci. 2006, 85:947-954.
40. Lee S.C., Chan J., Clement M.V., Pervaiz S. Functional proteomics of resveratrol-induced colon cancer cell apoptosis: caspase-6-mediated cleavage of lamin A is a major signaling loop. Proteomics 2006, 6:2386-2394.
41. Lee J., Banu S.K., Nithy T.K., Stanley J.A., Arosh J.A. Early pregnancy induced expression of prostaglandin E2 receptors EP2 and EP4 in the ovine endometrium and regulated by interferon tau through multiple cell signaling pathways. Mol. Cell. Endocrinol. 2012, 348:211-223.
42. Leonard S.S., Xia C., Jiang B.H., Stinefelt B., Klandorf H., Harris G.K., Shi X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003, 309:1017-1026.
43. Li L., Chen X., Zhu Q., Chen D., Guo J., Yao W., Dong Y., Wei J., Lian Q., Ge R.S., Yuan B. Disrupting androgen production of Leydig cells by resveratrol via direct inhibition of human and rat 3beta-hydroxysteroid dehydrogenase. Toxicol. Lett. 2014, 226:14-19.
44. Lim J., Nakamura B.N., Mohar I., Kavanagh T.J., Luderer U. Glutamate cysteine ligase modifier subunit (Gclm) null mice have increased ovarian oxidative stress and accelerated age-related ovarian failure. Endocrinology 2015, 156:3329-3343.
45. Lin C.J., Chen T.H., Yang L.Y., Shih C.M. Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. Cell Death Dis. 2014, 5.
46. Littell R.C., Stroup W.W., Milliken G.A., Wolfinger R.D., Schabenberger O. Mixed Model Diagnostics, SAS for Mixed Models 2006, 413-437. SAS institute, Cary, NC, USA.
47. Liu K., Jin B., Wu C., Yang J., Zhan X., Wang L., Shen X., Chen J., Chen H., Mao Z. NQO1 Stabilizes p53 in response to oncogene-induced senescence. Int. J. Biol. Sci. 2015, 11:762-771.
48. Lopez-Burillo S., Tan D.X., Mayo J.C., Sainz R.M., Manchester L.C., Reiter R.J. Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions. J. Pineal Res. 2003, 34:269-277.
49. Macarulla M., Alberdi G., Gómez S., Tueros I., Bald C., Rodriguez V., Martínez J., Portillo M. Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet. J. Physiol. Biochem. 2009, 65:369-376.
50. Malott V. West county road 112: Midland Texas. Environmental Protection Agency 2015, 1-6.
51. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 2000, 164:6509-6519.
52. Martucci C.P., Fishman J. P450 enzymes of estrogen metabolism. Pharmacol. Ther. 1993, 57:237-257.
53. McNeill L.S., McLean J.E., Parks J.L., Edwards M.A. Hexavalent Chromium review, part 2: chemistry, occurrence, and treatment. J. Am. Water Works Assoc. 2012, 104:E395-E405.
54. Mojica-Villegas M.A., Izquierdo-Vega J.A., Chamorro-Cevallos G., Sanchez-Gutierrez M. Protective effect of resveratrol on biomarkers of oxidative stress induced by iron/ascorbate in mouse spermatozoa. Nutrients 2014, 6:489-503.
55. Morita Y., Wada-Hiraike O., Yano T., Shirane A., Hirano M., Hiraike H., Koyama S., Oishi H., Yoshino O., Miyamoto Y., Sone K., Oda K., Nakagawa S., Tsutsui K., Taketani Y. Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary. Reprod. Biol. Endocrinol. 2012, 10:14.
56. Morita Y., Wada-Hiraike O., Yano T., Shirane A., Hirano M., Hiraike H., Koyama S., Oishi H., Yoshino O., Miyamoto Y., Sone K., Oda K., Nakagawa S., Tsutsui K., Taketani Y. Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary. Reprod. Biol. Endocrinol. 2012, 10:14.
57. Nickens K.P., Patierno S.R., Ceryak S. Chromium genotoxicity: a double-edged sword. Chem. Biol. Interact. 2010, 188:276-288.
58. Ortega I., Duleba A.J. Ovarian actions of resveratrol. Ann. N. Y. Acad. Sci. 2015, 1348:86-96.
59. Ortega I., Villanueva J.A., Wong D.H., Cress A.B., Sokalska A., Stanley S.D., Duleba A.J. Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of AKT/PKB signaling pathway. Endocrinology 2012, 153:4019-4029.
60. Ortega I., Wong D.H., Villanueva J.A., Cress A.B., Sokalska A., Stanley S.D., Duleba A.J. Effects of resveratrol on growth and function of rat ovarian granulosa cells. Fertil. Steril. 2012, 98:1563-1573.
61. Ortega I., Villanueva J.A., Wong D.H., Cress A.B., Sokalska A., Stanley S.D., Duleba A.J. Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis. J. Ovarian Res. 2014, 7:21.
62. Osman P. Rate and course of atresia during follicular development in the adult cyclic rat. J. Reprod. Fertil. 1985, 73:261-270.
63. Raftogianis R., Creveling C., Weinshilboum R., Weisz J. Chapter 6: estrogen metabolism by conjugation. JNCI Monographs 2000, 2000:113-124.
64. Rao G.T., Rao V.V.S.G., Ranganathan K., Surinaidu L., Mahesh J., Ramesh G. Assessment of groundwater contamination from a hazardous dump site in Ranipet, Tamil Nadu, India. Hydrogeol. J. 2011, 19:1587-1598.
65. Rocha-Gonzalez H.I., Ambriz-Tututi M., Granados-Soto V. Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases. CNS Neurosci. Ther. 2008, 14:234-247.
66. Rubiolo J.A., Mithieux G., Vega F.V. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol. 2008, 591:66-72.
67. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 2008, 3:1101-1108.
68. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996, 56:2979-2984.
69. Shin S.M., Cho I.J., Kim S.G. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3β inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol. Pharmacol. 2009, 76:884-895.
70. Shin J.A., Oh S., Ahn J.H., Park E.M. Estrogen receptor-mediated resveratrol actions on blood-brain barrier of ovariectomized mice. Neurobiol. Aging 2015, 36:993-1006.
71. Shmitova L.A. Content of hexavalent chromium in the biological substrates of pregnant women and puerperae engaged in the manufacture of chromium compounds. Gig. Tr. Prof. Zabol. 1980, 33-35.
72. Simsek Y., Gurocak S., Turkoz Y., Akpolat N., Celik O., Ozer A., Yilmaz E., Turhan U., Ozyalin F. Ameliorative effects of resveratrol on acute ovarian toxicity induced by total body irradiation in young adult rats. J. Pediatr. Adolesc. Gynecol. 2012, 25:262-266.
73. Sivakumar K.K., Stanley J.A., Arosh J.A., Pepling M.E., Burghardt R.C., Banu S.K. Prenatal exposure to chromium induces early reproductive senescence by increasing germ cell apoptosis and advancing germ cell cyst breakdown in the F1 offspring. Dev. Biol. 2014, 388:22-34.
74. Spink B.C., Katz B.H., Hussain M.M., Pang S., Connor S.P., Aldous K.M., Gierthy J.F., Spink D.C. SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells. Carcinogenesis 2000, 21:1947-1957.
75. Stanley J.A., Lee J., Nithy T.K., Arosh J.A., Burghardt R.C., Banu S.K. Chromium-VI arrests cell cycle and decreases granulosa cell proliferation by down-regulating cyclin-dependent kinases (CDK) and cyclins and up-regulating CDK-inhibitors. Reprod. Toxicol. 2011, 32:112-123.
76. Stanley J.A., Sivakumar K.K., Nithy T.K., Arosh J.A., Hoyer P.B., Burghardt R.C., Banu S.K. Postnatal exposure to chromium through mother's milk accelerates follicular atresia in F1 offspring through increased oxidative stress and depletion of antioxidant enzymes. Free Radic. Biol. Med. 2013, 61C:179-196.
77. Stanley J.A., Sivakumar K.K., Arosh J.A., Burghardt R.C., Banu S.K. Edaravone mitigates hexavalent chromium-induced oxidative stress and depletion of antioxidant enzymes while estrogen restores antioxidant enzymes in the rat ovary in F1 offspring. Biol. Reprod. 2014, 91:12.
78. Stanley J.A., Arosh J.A., Burghardt R.C., Banu S.K. A fetal whole ovarian culture model for the evaluation of CrVI-induced developmental toxicity during germ cell nest breakdown. Toxicol. Appl. Pharmacol. 2015, 289:58-69.
79. Supornsilchai V., Svechnikov K., Seidlova-Wuttke D., Wuttke W., Soder O. Phytoestrogen resveratrol suppresses steroidogenesis by rat adrenocortical cells by inhibiting cytochrome P450 c21-hydroxylase. Horm. Res. 2005, 64:280-286.
80. Svechnikov K., Spatafora C., Svechnikova I., Tringali C., Soder O. Effects of resveratrol analogs on steroidogenesis and mitochondrial function in rat Leydig cells in vitro. J. Appl. Toxicol. 2009, 29:673-680.
81. Talalay P., Dinkova-Kostova A.T., Holtzclaw W.D. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv. Enzym. Regul. 2003, 43:121-134.
82. Townsend D.M., Tew K.D., Tapiero H. The importance of glutathione in human disease. Biomed. Pharmacother. 2003, 57:145-155.
83. Ungvari Z., Orosz Z., Rivera A., Labinskyy N., Xiangmin Z., Olson S., Podlutsky A., Csiszar A. Resveratrol increases vascular oxidative stress resistance. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2417-H2424.
84. USEPA National primary drinking water regulations. In US-Environmental-Protection-Agency, (Ed.), EPA 816-F-09-004 2009, 1-6.
85. Webster I.A. Hinkley Groundwater Remediation Project - IRP Manager Community Briefing No. 5. Project Navigator Ltd 2012, 1-40.
86. Yu C.W., Shin Y.G., Chow A., Li Y.M., Kosmeder J.W., Lee Y.S., Hirschelman W.H., Pezzuto J.M., Mehta R.G., van Breemen R.B. Human, Rat, and Mouse Metabolism of Resveratrol 2002.
87. Yu W., Fu Y.-C., Wang W. Cellular and molecular effects of resveratrol in health and disease. J. Cell. Biochem. 2012, 113:752-759.
88. Zhang J.D., Li X.L. Chromium pollution of soil and water in Jinzhou. Zhonghua yu fang yi xue za zhi [Chin. J. prev. Med.] 1987, 21:262-264.
89. Zhang Y., Liu Y., Wang T., Li B., Li H., Wang Z., Yang B. Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem. Biophys. Res. Commun. 2006, 340:1192-1199.
90. Zhao X.Y., Li G.Y., Liu Y., Chai L.M., Chen J.X., Zhang Y., Du Z.M., Lu Y.J., Yang B.F. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br. J. Pharmacol. 2008, 154:105-113.